Jie Xu
- Molecular Biology top 1%
- Oncology top 1%
- Cancer Research top 1%
- Immunology top 2%
- Epidemiology top 5%
- Topics
- Lymphoma Diagnosis and Treatment (26 papers)Cancer Immunotherapy and Biomarkers (18 papers)Acute Myeloid Leukemia Research (16 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Jie Xu
245 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Molecular Biology 4.2k
- Oncology 2.4k
- Cancer Research 1.6k
- Immunology 1.2k
- Epidemiology 823
Countries citing papers authored by Jie Xu
This map shows the geographic impact of Jie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Xu more than expected).
Fields of papers citing papers by Jie Xu
This network shows the impact of papers produced by Jie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Xu. The network helps show where Jie Xu may publish in the future.
Co-authorship network of co-authors of Jie Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Xu. A scholar is included among the top collaborators of Jie Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Xu. Jie Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 10 | |
| 8 | 15 | |
| 9 | 23 | |
| 10 | 5 | |
| 11 | 5 | |
| 12 | 58 | |
| 13 | 1 | |
| 14 | Expression of endoplasmic reticulum oxidoreductase 1-α in cholangiocarcinoma tissues and its effects on the proliferation and migration of cholangiocarcinoma cells | 2 |
| 15 | 12 | |
| 16 | 32 | |
| 17 | 231 | |
| 18 | 89 | |
| 19 | 4 | |
| 20 | 282 |
About Jie Xu
Jie Xu is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 256 papers that have together received 8.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Acute Myeloid Leukemia Research (16 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.4k citations) and Molecular Biology (4.2k citations). Jie Xu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Jing‐Yuan Fang, Luoyan Ai, Han Yao, Chushu Li, Lunxi Liang, Huanbin Wang, Antao Xu, Jilin Wang, Xiaolin Zhou and Jin Qian. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.